Anton Petrov

COO at Mitotech

Speaker

Dr. Anton Petrov is the Chief Operations Officer at Mitotech – a clinical-stage drug development company focused on development of mitochondria-targeted drugs. He supervises the operations behind Mitotech's drug development process in the U.S. and EU, concentrating on preclinical and clinical segments for various therapeutic indications, including metabolic diseases. He has worked in biotechnology for more than two decades and held management positions at several biotech start-ups prior to joining Mitotech. He holds a PhD degree from the University of Southern California and MBA degree from INSEAD.